PSA Advisories

The Current State of “Wrong Patient” Insulin Pen Injections

Thousands of patients in the United States have received injections from potentially contaminated insulin pens, typically involving inappropriate or unrecognized sharing of a patient’s previously used insulin pen device. Analyst query of the Pennsylvania Patient Safety Reporting System identified 82 reports of potential or actual wrong-patient errors with the use of insulin pen devices in Pennsylvania from 2005 through 2014. Over half (n = 43) of the reports describe actual administration events, 35.4% (n = 29) were close calls, and the remaining 12.2% (n = 10) did not indicate whether or not administration took place. Nearly two-thirds (n = 54) of the 82 events, including 67.4% (n = 29) of the actual administration events, occurred during 2013 or 2014. Despite widespread media coverage, recommendations from national organizations, and application of strategies considered best practices, wrong-patient insulin pen injections continue to occur. Hospitals are encouraged to analyze their own wrong-patient events with the use of insulin pens and examine their current insulin practices as they decide whether to use insulin pens, vials, or a combination of the two. (Pa Patient Saf Advis 2015 Sep;12[3]:110-15.)

Please click here for the complete article on the Pennsylvania Patient Safety Authority’s website.

More Alerts

Since the 2021-22 influenza (flu) vaccine became available last month, the Institute for Safe Medication Practices (ISMP) has received 16 cases of accidental influenza and coronavirus disease 2019 (COVID-19) vaccine mix-ups. All reports were sent by consumers or healthcare practitioners via one of
ISMP has received reports from two different hospitals about McKesson packaged levetiracetam 250 unit dose blister packages that have a barcode that scans as naproxen 500 mg. Apparently one side of the unit dose blister of 10 levetiracetam tablets scans properly, but the barcode on other side
URGENT – HAZARDOUS SITUATION – PLEASE REACT IMMEDIATELY ISMP is aware of an extremely hazardous packaging error involving certain cisatracurium products from Meitheal Pharmaceuticals. While the outer carton identifies the vials inside as cisatracurium, the vials contained in the carton are labeled